Results 131 to 140 of about 14,076 (220)

LR11/SorLA and its role in cardiovascular disease. [PDF]

Int J Cardiol Heart Vasc
Kloosterman M, Vongpromek R, Friesema ECH, Bramer W, Verhoeven AJM, Mulder MT.   +5 more
europepmc   +1 more source

uPAR-Targeting Cytotoxic Antibody-Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications. [PDF]

Cells
Xiang H, Mortenson GP, Lang SB, Jakkaraju S, Chirala A, Zhu Y, Jia M, Wen J, Chen Y, Baghela A, Chen YC, Sze MA, Hegde LG, Zhang-Hoover J, Willingham A, Handa M, Chi A, Baltus GA, Kamath RV, Levesque MC, Vollmann EH.   +20 more
europepmc   +1 more source

Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness. [PDF]

Am J Respir Cell Mol Biol
Whitehead GS, Nakano K, Wilkinson CL, Patterson AM, Upadhyay S, Massri AJ, Papas BN, Gruzdev A, Ray M, Nakano H, Cook DN.   +10 more
europepmc   +1 more source

Plasminogen Activation System and Fibroblasts: Impact on Tissue Remodeling, Disease, and Organ Homeostasis. [PDF]

Inflammation
Moideen FM, Bhandary YP.
europepmc   +1 more source

High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer. [PDF]

Pathophysiology
Gong W, Liu Y, Falkenberg N, Kiechle M, Bronger H, Dorn J, Magdolen V, Dreyer T.   +7 more
europepmc   +1 more source

Tissue-Based Biomarkers for Fluorescence-Guided Surgery of Pancreatic Ductal Adenocarcinoma: A Systematic Review. [PDF]

Curr Issues Mol Biol
Boalot A, Younes A, Woodward CJ, Alelaimi A, Arabaci F, Lee D, Ozber CH, Heger M, Khaled YS.   +8 more
europepmc   +1 more source

High serum urokinase-type plasminogen activator receptor correlates with sepsis-induced cardiomyopathy in sepsis patients. [PDF]

Front Med (Lausanne)
He J, Wu T, Wu G, Huang Y, Yin X, Zhang M, Fang B, Guo L.   +7 more
europepmc   +1 more source

Unveiling the Importance of the Expression of LY6/UPAR Gene Family Members in Urothelial Carcinoma of the Urinary Bladder. [PDF]

Biomedicines
Kökenek Ünal TD, Korkmaz Bayram K, Barokah AN, Bayazit Gözüküçük B, Inan U, Topal E, Özkul Y.   +6 more
europepmc   +1 more source

A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy. [PDF]

Cell
Zhang Z, Ho YJ, Fang X, Kim M, Li M, Luan W, Hinterleitner C, Haubner S, Kogel F, Pratt EC, Ozcelik E, Reyes J, Jiang Q, Yang VW, Chen YJ, Wang T, Liu H, Hu H, Zhuang X, Park J, Paffenholz SV, Chen K, Chang Q, Kulick A, Zhang J, Chan E, Rosiek E, Fan N, Williams RA, Wang AC, Freeman S, Tian S, Gunset G, Garcia Angus A, Lecomte N, Yildirim SY, Ali E, Wu M, Miranda IC, Antonescu CR, Basturk O, Tarcan Z, Rekhtman N, Wilson C, Basar M, Sauter JL, Al-Ahmadie HA, Singer S, Iacobuzio-Donahue C, Rudin C, de Stanchina E, Ganesh K, Romesser PB, Weigelt B, Huh DD, Leibold J, Feucht J, Vázquez-García I, Bott MJ, Zamarin D, Shah SP, Lewis JS, Amor C, Pe'er D, Mansilla-Soto J, Filliol A, Sadelain M, Lowe SW.   +67 more
europepmc   +1 more source

[Retracted] Downregulation of uPA/uPAR inhibits intermittent hypoxia‑induced epithelial‑mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells. [PDF]

Int J Oncol
Gupta R, Chetty C, Bhoopathi P, Lakka S, Mohanam S, Rao AS, Dinh DH.   +6 more
europepmc   +1 more source